To Evaluate the Immunogenicity and Safety of Sequential Immunization Schedules of Sabin IPV and bOPV

NCT04054492 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

604

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaccination
Reaction - Vaccine

Interventions

BIOLOGICAL: Sabin-IPV+bOPV+bOPV
BIOLOGICAL: Sabin-IPV+Sabin-IPV+bOPV
BIOLOGICAL: Sabin-IPV+Sabin-IPV+Sabin-IPV

Sponsor

China National Biotec Group Company Limited

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]